Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001047469-20-003702
Filing Date
2020-06-18
Accepted
2020-06-18 16:16:35
Documents
4

Document Format Files

Seq Description Document Type Size
1 PRER14A a2241918zprer14a.htm PRER14A 316170
2 G957926.JPG g957926.jpg GRAPHIC 37583
3 G534329.JPG g534329.jpg GRAPHIC 11540
4 G213072BGI001.GIF g213072bgi001.gif GRAPHIC 159632
  Complete submission text file 0001047469-20-003702.txt   605049
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-36714 | Film No.: 20972777
SIC: 2834 Pharmaceutical Preparations